Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Operating Expenses: 2020-2021

Historic Operating Expenses for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $1.8 million.

  • Bright Minds Biosciences' Operating Expenses rose 2485.36% to $1.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2021, which is 4176.18% up from last year.
  • Bright Minds Biosciences' Operating Expenses amounted to $1.8 million in Q3 2021, which was up 819.43% from $198,724 recorded in Q2 2021.
  • Bright Minds Biosciences' Operating Expenses' 5-year high stood at $1.8 million during Q3 2021, with a 5-year trough of $70,672 in Q3 2020.
  • Moreover, its 2-year median value for Operating Expenses was $291,624 (2020), whereas its average is $646,642.
  • Data for Bright Minds Biosciences' Operating Expenses shows a peak YoY soared of 2,485.36% (in 2021) over the last 5 years.
  • Over the past 2 years, Bright Minds Biosciences' Operating Expenses (Quarterly) stood at $291,624 in 2020, then surged by 2,485.36% to $1.8 million in 2021.
  • Its Operating Expenses stands at $1.8 million for Q3 2021, versus $198,724 for Q2 2021 and $845,067 for Q1 2021.